Health Products Type I ? Class 1/Type I = High risk (serious health hazard). Class 2/Type II = Moderate risk. Class 3/Type III = Low risk. Updated 2022-01-26

APO-AMITRIPTYLINE 10mg: NDMA impurity

See all recalls from APO-AMITRIPTYLINE →
Share: Facebook X / Twitter WhatsApp

Recalled Product

APO-AMITRIPTYLINE 10mg


✅ What Should You Do?

  1. 🛑 Stop using this product immediately and set it aside.
  2. Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication.
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report an adverse reaction to Health Canada MedEffect
Looking for a safe alternative? Search Amazon Canada for APO-AMITRIPTYLINE 10mg →

Hazard / Issue

Product safety

Issued by

Drugs and health products

⚠️ What You Should Do

Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication. Stopping amitriptyline may lead to mild withdrawal symptoms.Contact your health care provider if you have taken a recalled product and you have concerns about your health. Ask your pharmacist if you are unsure whether you are taking a recalled product.Contact the company if you have questions about the recall:Apotex Inc. via Sedgwick by calling at 1-888-266-7914, or by email at apotex5117@sedgwick.comAA Pharma at 1-905-669-1565Report any health product-related side effects or complaints to Health Canada.
View official government recall